NewCardio, Inc. (NWCI)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
At close: Aug 4, 2025
NewCardio Revenue
NewCardio had revenue of $9.88K in the quarter ending September 30, 2011, a decrease of -90.04%. This brings the company's revenue in the last twelve months to $238.58K, up 40.90% year-over-year. In the year 2010, NewCardio had annual revenue of $257.40K.
Revenue (ttm)
238.58K
Revenue Growth
+40.90%
P/S Ratio
0.02
Revenue / Employee
23.86K
Employees
10
Market Cap
4.08K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2010 | 257.40K | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |